Tenthpin
The Trusted Advisor for Data-Driven Patient- Centric Value Chain Management in Life Sciences

With the current COVID-19 pandemic, the life sciences industry is at the epicenter of disruption and innovation—supplying vital support to patients in their time of need and also sprinting ahead to develop new vaccines. In the backend, making all this possible is the intelligent collaboration between various life science companies regardless of the size or location. Pfizer, one of the world’s largest pharmaceutical companies, has collaborated with BioNTech, until recently a lesser-known German-based biotechnology firm, to develop the first authorized COVID-19 vaccine. Empowering BioNTech’s collaboration processes is Tenthpin, a global management firm. “We consult companies like BioNTech to design resilient operating models and agile processes with underlying technology innovations,” says Patrick Wolf, partner at Tenthpin. A trusted advisor to various reputed life sciences organizations as management and technology consultants, the company understands unique challenges across the entire value chain and provides independent, unbiased advice and services combining its deep industry expertise with advanced technologies.

Wolf observes that the COVID-19 pandemic has accelerated the need for digitalization in the life sciences industry, and most organizations are inundated with few roadblocks. First and foremost is the need for agility and flexibility to effectively collaborate and interact with various business partners, be it suppliers, customers, logistics, or IT service providers. The companies also have to effectively utilize their capabilities in a partnership ecosystem to achieve ultimatelya seamless integration. Further, many organizations now realize that their manufacturing and distribution networks are not resilient enough to easily adapt their networks and recover from any negative impact due to COVID-19. Considering these challenges, Tenthpin offers an innovative and extensive toolset comprising state-of-the-art technologies to help clients drive transformational change and achieve their desired outcomes. Through a delivery-focused approach, the company implements solutions that make business strategies work and gain competitive advantages.

Tenthpin provides comprehensive solutions and services portfolio to meet various requirements of life sciences companies,be it in the sector of Cell & Gene Therapy or mass production of vaccines.

Within the end-to-end consulting services, Tenthpin helps clients accelerate their digital transformation by restructuring existing roadmaps and identifying the initiatives that can bring maximum business value. The company’s solutions combine the digitalization of processes, data management, and analytics. For instance, Tenthpin is piloting an RPAbased solution for managing products short of supply by determining which market to service first automatically based on pre-defined business rules. Similarly, the company has forged a partnership with a disruptive startup to provide AR solutions that guide operators on the shop floor to effectively maintain a single machine or an entire production line. Being SAP Partner, Tenthpin harnesses SAP’s capabilities to facilitate solution engineering along with implementation that provides business value—be it a traditional end-to-end ERP implementation or innovative digital solutions like RPA. “We understand ourselves as a boutique consultancy that provides end-to-end consulting services within the niche of life sciences industry,” comments Wolf.

Tenthpin is undoubtedly revolutionizing the life sciences industry through its innovative services.

We understand ourselves as a boutique consultancy that provides end-toend consulting services with a clear focus on the life sciences industry

In tandem with the industry’s focus on improving patient outcomes and experiences, the company is embracing the model of a data-driven patientcentric value chain. This is further illustrated by Tenthpin’s co-innovation with SAP ‘Clinical Trial Supply Management’ to support the end-to-end clinical supply chain. “The emphasis on placing patients in the middle of all operations has increased with the current pandemic and this drives our solution and service offerings,” remarks Wolf. With two decades of management consulting experience, Wolf is steering Tenthpin ahead with this breakthrough mission and leading its global Service Line Supply Chain Management.

Highlighting Tenthpin’s ability to deliver successful projects, Wolf cites an instance wherein the company helped a global biotech firm analyze its manufacturing and distribution footprint and value chains. The client relied on active pharmaceutical ingredients (APIs) from China and wanted to assess the impact on their downstream operations in Europe and the U.S. when the pandemic hit. Even with sophisticated Advanced Planning Systems and several weeks spent on the issue, the client failed to quantify the risk of potential shut down of API supply. Once Tenthpin was brought onboard, the team headed by Wolf set up a digital supply chain twin with all the required data from the ERP system. Within only a few days, the company was able to assess the risk, days until the shortage of certain products in the European market, and its financial impact. Impressed by Tenthpin’s solution, the client is using it on a regular basis to make tactical decisions now.

As a partner-owned company, Tenthpin’s unique capabilities are bolstered by its expert team comprising five founding partners and 23 partners from across the globe. Leveraging their deep industry and process knowledge, partners drive the client interaction efficiently from initial conversation to ongoing support after implementation. The partners’ capabilities can easily be demonstrated considering Wolf’s achievements. He has 20 years of consulting experience in management consulting, from strategy through implementation. Wolf has worked with various life sciences companies, leading large-sized global supply chain transformation programs, developing disruptive and innovative operating models.

Having carved a unique niche in the industry with ingenious services, Tenthpin plans to refocus on demand for data-driven patient-centric value chain management for life sciences companies. The company has also extended its capabilities in analytics by hiring new partners in the area. Further, Tenthpin is all set to inaugurate its digital innovation hub with experienced solution architects and data scientists in India in January 2021 to expand its international footprint and look forward to doubling size within one year. “With our holistic data-driven patient-centric value chain management approach, we are well prepared for the next disruption and see a bright future in life sciences industry,” concludes Wolf.